1. Home
  2. XLO vs ZGM Comparison

XLO vs ZGM Comparison

Compare XLO & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • ZGM
  • Stock Information
  • Founded
  • XLO 2016
  • ZGM 2019
  • Country
  • XLO United States
  • ZGM Macau
  • Employees
  • XLO N/A
  • ZGM N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • ZGM Professional Services
  • Sector
  • XLO Health Care
  • ZGM Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • ZGM Nasdaq
  • Market Cap
  • XLO 40.9M
  • ZGM 43.6M
  • IPO Year
  • XLO 2021
  • ZGM 2025
  • Fundamental
  • Price
  • XLO $0.82
  • ZGM $3.27
  • Analyst Decision
  • XLO Buy
  • ZGM
  • Analyst Count
  • XLO 2
  • ZGM 0
  • Target Price
  • XLO $3.00
  • ZGM N/A
  • AVG Volume (30 Days)
  • XLO 469.6K
  • ZGM 190.1K
  • Earning Date
  • XLO 11-07-2025
  • ZGM 01-06-2026
  • Dividend Yield
  • XLO N/A
  • ZGM N/A
  • EPS Growth
  • XLO N/A
  • ZGM 401.52
  • EPS
  • XLO N/A
  • ZGM 0.17
  • Revenue
  • XLO $15,001,000.00
  • ZGM $3,620,780.00
  • Revenue This Year
  • XLO $519.70
  • ZGM N/A
  • Revenue Next Year
  • XLO $44.57
  • ZGM N/A
  • P/E Ratio
  • XLO N/A
  • ZGM $18.66
  • Revenue Growth
  • XLO 536.45
  • ZGM 211.78
  • 52 Week Low
  • XLO $0.62
  • ZGM $2.00
  • 52 Week High
  • XLO $1.70
  • ZGM $4.51
  • Technical
  • Relative Strength Index (RSI)
  • XLO 57.82
  • ZGM N/A
  • Support Level
  • XLO $0.73
  • ZGM N/A
  • Resistance Level
  • XLO $0.85
  • ZGM N/A
  • Average True Range (ATR)
  • XLO 0.05
  • ZGM 0.00
  • MACD
  • XLO 0.00
  • ZGM 0.00
  • Stochastic Oscillator
  • XLO 65.97
  • ZGM 0.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.

Share on Social Networks: